Skip to main content
Caplight Logo









SYMBYX Biome

SYMBYX Biome

Private
SydneyHealthcare & Life Scienceshttps://symbyxbiome.com/

Last Round

Series A

May 1, 2021

Total Funding Raised

$2.56M

Company Overview

SYMBYX Biome is a medical technology company that develops and markets innovative, clinically backed light therapy and photobiomodulation devices for the management of chronic conditions such as Parkinson's disease, fibromyalgia, and inflammation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

photobiomodulationPBMlight therapyred light therapyParkinson's treatmentat-home medical devicenear-infrared therapygut-brain axisneurodegenerative diseasebiohackingnon-pharmaceutical therapytelemedicinemed-techDTC medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SYMBYX Biome Comparables

Compare SYMBYX Biome with similar companies based on industry and business-model similarity.

SYMBYX Biome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Well Red Pty Ltd
88%
Vielight Inc.
83%
PhotoPharmics
82%

SYMBYX Biome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2021

Key People

Founding team and executive leadership

Wayne Markman

Co-Founder and CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 7, 2024

    Grew 19% QoQ from 16 to 19 employees.

  • May 1, 2021

    $2.56M round with participation from multiple investors.

SYMBYX Biome Filings

Explore SEC and related filing metadata, where available.

SYMBYX Biome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SYMBYX Biome's valuation, stock price, and market status.

Is SYMBYX Biome a public or private company?

SYMBYX Biome is a private company.

What is the current stock price of SYMBYX Biome?

SYMBYX Biome is a private company with no public stock price. No recent secondary market data is available.

How much is SYMBYX Biome worth (valuation)?

Valuation information for SYMBYX Biome is not publicly available.

Can I buy SYMBYX Biome stock?

SYMBYX Biome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SYMBYX Biome's last funding round?

SYMBYX Biome's most recent funding round was Series A on May 1, 2021.

Who are the main investors in SYMBYX Biome?

Investor information for SYMBYX Biome is not publicly disclosed.

Will SYMBYX Biome IPO soon?

No public IPO plans have been announced for SYMBYX Biome.

How can I track SYMBYX Biome secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SYMBYX Biome's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range14
Year Founded2020
Last FundingMay 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?